Safety and efficacy of changing to the travoprost/timolol maleate fixed combination (DuoTrav) from prior mono- or adjunctive therapy.

Clin Ophthalmol · 2010 · PMC2874274 · PMID 20505839

Europe PMC DOI

hedged sentence

0.0800

closest p · 1.6× alpha

0.0800

boldest claim

The sentences

approaching significanceP = 0.08so close (0.05 < p ≤ 0.1)

Following the modified Bonferroni correction, there was a reduced incidence of ocular pain with the travoprost/timolol fixed combination ( P = 0.01) and a reduction in eyelid crusting that was approaching significance ( P = 0.08).

also in 1,607 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.